The frequency of cardiac valvular regurgitation in Parkinson's disease
Identifieur interne : 002584 ( Main/Exploration ); précédent : 002583; suivant : 002585The frequency of cardiac valvular regurgitation in Parkinson's disease
Auteurs : Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi [Japon] ; Taku Hatano [Japon] ; Takao Urabe [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Yoshitaka Iwama [Japon] ; Hiroyuki Daida [Japon] ; Michi Sakai [Japon] ; Takeo Nakayama [Japon] ; Yoshikuni Mizuno [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-05-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Aortic Valve Insufficiency (chemically induced), Aortic Valve Insufficiency (epidemiology), Azepines (adverse effects), Azepines (therapeutic use), Benzothiazoles (adverse effects), Benzothiazoles (therapeutic use), Bromocriptine (adverse effects), Bromocriptine (therapeutic use), Cardiac valvular disease, Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Dopamine agonist, Ergolines (adverse effects), Ergolines (therapeutic use), Female, Humans, Male, Mitral Valve Insufficiency (chemically induced), Mitral Valve Insufficiency (epidemiology), Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Pergolide (adverse effects), Pergolide (therapeutic use), Prevalence, Valvular regurgitation, cardiac valvulopathy, dopamine agonist, valvular regurgitation.
- MESH :
- chemical , adverse effects : Azepines, Benzothiazoles, Bromocriptine, Dopamine Agonists, Ergolines, Pergolide.
- chemically induced : Aortic Valve Insufficiency, Mitral Valve Insufficiency.
- drug therapy : Parkinson Disease.
- epidemiology : Aortic Valve Insufficiency, Mitral Valve Insufficiency, Parkinson Disease.
- chemical , therapeutic use : Azepines, Benzothiazoles, Bromocriptine, Dopamine Agonists, Ergolines, Pergolide.
- Aged, Female, Humans, Male, Prevalence.
Abstract
To investigate the frequency of cardiac valve regurgitation related with low dose dopamine agonists in patients with Parkinson's disease (PD), echocardiograms were analyzed in 527 consecutive PD patients (448 patients treated with dopamine agonists, 79 patients never treated with dopamine agonists as age‐matched controls). The frequency of mild or above mild regurgitation of the aortic valve (AR) was significantly higher in the cabergoline group (13.7%, P < 0.05) compared with the controls (2.5%). Odds ratio adjusted by age and sex for AR was significantly higher in the cabergoline group (OR, 6.45; 95% CI, 1.46–28.60; P = 0.01): odds ratio was significantly higher in patients treated with higher daily doses (OR, 14.41; 95% CI, 3.08–67.38; P = 0.0007) and higher cumulative doses (OR, 15.29; 95% CI, 3.19–73.18; P = 0.0006). No statistical difference was identified in the frequency of the tricuspid and mitral regurgitation. None of the other dopamine agonist groups including pergolide gave higher frequency or higher odds ratio compared with the controls. None of our patients showed severe regurgitation or was operated for valvular heart disease. The question as to whether or not longer duration of low dose dopamine agonist treatment would yield the same results needs further studies. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22036
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001561
- to stream Istex, to step Curation: 001561
- to stream Istex, to step Checkpoint: 001140
- to stream PubMed, to step Corpus: 002260
- to stream PubMed, to step Curation: 002260
- to stream PubMed, to step Checkpoint: 002039
- to stream Ncbi, to step Merge: 002101
- to stream Ncbi, to step Curation: 002101
- to stream Ncbi, to step Checkpoint: 002101
- to stream Main, to step Merge: 003162
- to stream PascalFrancis, to step Corpus: 001234
- to stream PascalFrancis, to step Curation: 001A85
- to stream PascalFrancis, to step Checkpoint: 001063
- to stream Main, to step Merge: 003671
- to stream Main, to step Curation: 002584
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The frequency of cardiac valvular regurgitation in Parkinson's disease</title><author><name sortKey="Yamashiro, Kazuo" sort="Yamashiro, Kazuo" uniqKey="Yamashiro K" first="Kazuo" last="Yamashiro">Kazuo Yamashiro</name></author><author><name sortKey="Komine Obayashi, Miki" sort="Komine Obayashi, Miki" uniqKey="Komine Obayashi M" first="Miki" last="Komine-Kobayashi">Miki Komine-Kobayashi</name></author><author><name sortKey="Hatano, Taku" sort="Hatano, Taku" uniqKey="Hatano T" first="Taku" last="Hatano">Taku Hatano</name></author><author><name sortKey="Urabe, Takao" sort="Urabe, Takao" uniqKey="Urabe T" first="Takao" last="Urabe">Takao Urabe</name></author><author><name sortKey="Mochizuki, Hideki" sort="Mochizuki, Hideki" uniqKey="Mochizuki H" first="Hideki" last="Mochizuki">Hideki Mochizuki</name></author><author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name></author><author><name sortKey="Iwama, Yoshitaka" sort="Iwama, Yoshitaka" uniqKey="Iwama Y" first="Yoshitaka" last="Iwama">Yoshitaka Iwama</name></author><author><name sortKey="Daida, Hiroyuki" sort="Daida, Hiroyuki" uniqKey="Daida H" first="Hiroyuki" last="Daida">Hiroyuki Daida</name></author><author><name sortKey="Sakai, Michi" sort="Sakai, Michi" uniqKey="Sakai M" first="Michi" last="Sakai">Michi Sakai</name></author><author><name sortKey="Nakayama, Takeo" sort="Nakayama, Takeo" uniqKey="Nakayama T" first="Takeo" last="Nakayama">Takeo Nakayama</name></author><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:EC805026FDCE6364BD06263E84816A4BB4E1E850</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22036</idno><idno type="url">https://api.istex.fr/document/EC805026FDCE6364BD06263E84816A4BB4E1E850/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001561</idno><idno type="wicri:Area/Istex/Curation">001561</idno><idno type="wicri:Area/Istex/Checkpoint">001140</idno><idno type="wicri:doubleKey">0885-3185:2008:Yamashiro K:the:frequency:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18398916</idno><idno type="wicri:Area/PubMed/Corpus">002260</idno><idno type="wicri:Area/PubMed/Curation">002260</idno><idno type="wicri:Area/PubMed/Checkpoint">002039</idno><idno type="wicri:Area/Ncbi/Merge">002101</idno><idno type="wicri:Area/Ncbi/Curation">002101</idno><idno type="wicri:Area/Ncbi/Checkpoint">002101</idno><idno type="wicri:Area/Main/Merge">003162</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:08-0305148</idno><idno type="wicri:Area/PascalFrancis/Corpus">001234</idno><idno type="wicri:Area/PascalFrancis/Curation">001A85</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001063</idno><idno type="wicri:doubleKey">0885-3185:2008:Yamashiro K:the:frequency:of</idno><idno type="wicri:Area/Main/Merge">003671</idno><idno type="wicri:Area/Main/Curation">002584</idno><idno type="wicri:Area/Main/Exploration">002584</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The frequency of cardiac valvular regurgitation in Parkinson's disease</title><author><name sortKey="Yamashiro, Kazuo" sort="Yamashiro, Kazuo" uniqKey="Yamashiro K" first="Kazuo" last="Yamashiro">Kazuo Yamashiro</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Komine Obayashi, Miki" sort="Komine Obayashi, Miki" uniqKey="Komine Obayashi M" first="Miki" last="Komine-Kobayashi">Miki Komine-Kobayashi</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Hatano, Taku" sort="Hatano, Taku" uniqKey="Hatano T" first="Taku" last="Hatano">Taku Hatano</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Urabe, Takao" sort="Urabe, Takao" uniqKey="Urabe T" first="Takao" last="Urabe">Takao Urabe</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Mochizuki, Hideki" sort="Mochizuki, Hideki" uniqKey="Mochizuki H" first="Hideki" last="Mochizuki">Hideki Mochizuki</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Iwama, Yoshitaka" sort="Iwama, Yoshitaka" uniqKey="Iwama Y" first="Yoshitaka" last="Iwama">Yoshitaka Iwama</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Cardiology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Daida, Hiroyuki" sort="Daida, Hiroyuki" uniqKey="Daida H" first="Hiroyuki" last="Daida">Hiroyuki Daida</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Cardiology, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Sakai, Michi" sort="Sakai, Michi" uniqKey="Sakai M" first="Michi" last="Sakai">Michi Sakai</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Health Informatics, Kyoto University School of Public Health, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Nakayama, Takeo" sort="Nakayama, Takeo" uniqKey="Nakayama T" first="Takeo" last="Nakayama">Takeo Nakayama</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Health Informatics, Kyoto University School of Public Health, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Research Institute for diseases of Old Age, Juntendo University School of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-05-15">2008-05-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="935">935</biblScope><biblScope unit="page" to="941">941</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">EC805026FDCE6364BD06263E84816A4BB4E1E850</idno><idno type="DOI">10.1002/mds.22036</idno><idno type="ArticleID">MDS22036</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aortic Valve Insufficiency (chemically induced)</term><term>Aortic Valve Insufficiency (epidemiology)</term><term>Azepines (adverse effects)</term><term>Azepines (therapeutic use)</term><term>Benzothiazoles (adverse effects)</term><term>Benzothiazoles (therapeutic use)</term><term>Bromocriptine (adverse effects)</term><term>Bromocriptine (therapeutic use)</term><term>Cardiac valvular disease</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine Agonists (therapeutic use)</term><term>Dopamine agonist</term><term>Ergolines (adverse effects)</term><term>Ergolines (therapeutic use)</term><term>Female</term><term>Humans</term><term>Male</term><term>Mitral Valve Insufficiency (chemically induced)</term><term>Mitral Valve Insufficiency (epidemiology)</term><term>Nervous system diseases</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Pergolide (adverse effects)</term><term>Pergolide (therapeutic use)</term><term>Prevalence</term><term>Valvular regurgitation</term><term>cardiac valvulopathy</term><term>dopamine agonist</term><term>valvular regurgitation</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Azepines</term><term>Benzothiazoles</term><term>Bromocriptine</term><term>Dopamine Agonists</term><term>Ergolines</term><term>Pergolide</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Aortic Valve Insufficiency</term><term>Mitral Valve Insufficiency</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Aortic Valve Insufficiency</term><term>Mitral Valve Insufficiency</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azepines</term><term>Benzothiazoles</term><term>Bromocriptine</term><term>Dopamine Agonists</term><term>Ergolines</term><term>Pergolide</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Prevalence</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cardiopathie valvulaire</term><term>Insuffisance valvulaire</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Stimulant dopaminergique</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To investigate the frequency of cardiac valve regurgitation related with low dose dopamine agonists in patients with Parkinson's disease (PD), echocardiograms were analyzed in 527 consecutive PD patients (448 patients treated with dopamine agonists, 79 patients never treated with dopamine agonists as age‐matched controls). The frequency of mild or above mild regurgitation of the aortic valve (AR) was significantly higher in the cabergoline group (13.7%, P < 0.05) compared with the controls (2.5%). Odds ratio adjusted by age and sex for AR was significantly higher in the cabergoline group (OR, 6.45; 95% CI, 1.46–28.60; P = 0.01): odds ratio was significantly higher in patients treated with higher daily doses (OR, 14.41; 95% CI, 3.08–67.38; P = 0.0007) and higher cumulative doses (OR, 15.29; 95% CI, 3.19–73.18; P = 0.0006). No statistical difference was identified in the frequency of the tricuspid and mitral regurgitation. None of the other dopamine agonist groups including pergolide gave higher frequency or higher odds ratio compared with the controls. None of our patients showed severe regurgitation or was operated for valvular heart disease. The question as to whether or not longer duration of low dose dopamine agonist treatment would yield the same results needs further studies. © 2008 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Japon</li></country><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Yamashiro, Kazuo" sort="Yamashiro, Kazuo" uniqKey="Yamashiro K" first="Kazuo" last="Yamashiro">Kazuo Yamashiro</name></noRegion><name sortKey="Daida, Hiroyuki" sort="Daida, Hiroyuki" uniqKey="Daida H" first="Hiroyuki" last="Daida">Hiroyuki Daida</name><name sortKey="Hatano, Taku" sort="Hatano, Taku" uniqKey="Hatano T" first="Taku" last="Hatano">Taku Hatano</name><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name><name sortKey="Iwama, Yoshitaka" sort="Iwama, Yoshitaka" uniqKey="Iwama Y" first="Yoshitaka" last="Iwama">Yoshitaka Iwama</name><name sortKey="Komine Obayashi, Miki" sort="Komine Obayashi, Miki" uniqKey="Komine Obayashi M" first="Miki" last="Komine-Kobayashi">Miki Komine-Kobayashi</name><name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name><name sortKey="Mochizuki, Hideki" sort="Mochizuki, Hideki" uniqKey="Mochizuki H" first="Hideki" last="Mochizuki">Hideki Mochizuki</name><name sortKey="Nakayama, Takeo" sort="Nakayama, Takeo" uniqKey="Nakayama T" first="Takeo" last="Nakayama">Takeo Nakayama</name><name sortKey="Sakai, Michi" sort="Sakai, Michi" uniqKey="Sakai M" first="Michi" last="Sakai">Michi Sakai</name><name sortKey="Urabe, Takao" sort="Urabe, Takao" uniqKey="Urabe T" first="Takao" last="Urabe">Takao Urabe</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002584 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002584 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:EC805026FDCE6364BD06263E84816A4BB4E1E850
|texte= The frequency of cardiac valvular regurgitation in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |